Table II.
Clinical characteristics of patients following treatment of metastatic gastric tumors arising from renal cell carcinoma.
Characteristics | 3-year survival rate (%) | Median survival time (months) | P-value |
---|---|---|---|
Overall | 21 | 19 | |
Age (years) | 0.631 | ||
<68 | 28.6 | 24 | |
≥68 | 14.8 | 6 | |
Gender | 0.345 | ||
Male | 26.7 | 19 | |
Female | 0 | 5 | |
Tumor location | 0.102 | ||
Upper third | 0 | 24 | |
Middle third | 38.9 | 23 | |
Lower third | 20 | 5 | |
Tumor size (cm) | 0.067 | ||
<3 | 72.9 | - | |
≥3 | 11.1 | 5 | |
Gross appearance type | 0.030 | ||
Ulcerated | 28.6 | 24 | |
Protruding | 26.7 | 5 | |
Bleeding | 0.366 | ||
Yes | 26.7 | 23 | |
No | 0 | 4 | |
Metastasis | 0.133 | ||
Solitary | - | - | |
Multiple | 16.7 | 5 | |
IGM (years) | 0.017 | ||
<6.3 | 0 | 5 | |
≥6.3 | 28.6 | 24 | |
Therapy | 0.318 | ||
Resection | 30.7 | 24 | |
Palliative | 14.8 | 5 |
IGM, time interval between radical excision of the primary tumor and the diagnosis of gastric metastasis.